Literature DB >> 20731025

Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma.

Xiao-Dong Bu1, Nan Li, Xiao-Qiang Tian, Li Li, Jin-Song Wang, Xiao-Jin Yu, Pei-Lin Huang.   

Abstract

AIM: To study the expression profiles of MUC2 and MUC5AC in tumorigenesis of colorectal carcinoma and in its different pathologic types.
METHODS: Formalin-fixed, paraffin-embedded human colorectal tissue specimens were immunostained with antibodies against MUC2 and MUC5AC. Six samples of normal mucosa (NM), 12 samples of hyperplastic polyp (HP), 15 samples of tubular adenoma with low-grade dysplasia (LGD), 14 samples of tubular adenoma with high-grade dysplasia (HGD), 26 samples of conventional colorectal adenocarcinoma (CCA), 15 samples of mucinous carcinoma (MC), and 8 samples of signet-ring cell carcinoma (SRCC) were collected.
RESULTS: MUC2 was the most widely expressed protein in each study group, although the number of MUC2-positive cases was less in CCA group than in other groups (P < 0.05). The staining score for MUC2 was significantly decreased in the HP-LGD-HGD-CCA sequence (r = -0.73436, P < 0.0001). Among the neoplasms, MC and SRCC were more frequently associated with the high expression of MUC2 (P < 0.05) than with that of CCA. MUC5AC expression was detected in all groups but not in NM group. Furthermore, the staining score for MUC5AC was higher in HP, LGD, HGD, MC and SRCC groups than in NM and CCA groups (P < 0.05). The frequency of simultaneous expression of MUC proteins was significantly higher in MC and SRCC groups than in CCA group (P < 0.05).
CONCLUSION: Alterations in MUC expression occur during colorectal tumorigenesis. The transformation process in MC and SRCC may be different from that in the traditional adenoma-carcinoma sequence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20731025      PMCID: PMC2928465          DOI: 10.3748/wjg.v16.i32.4089

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Mucins as differentiation markers in bronchial epithelium. Squamous cell carcinoma and adenocarcinoma display similar expression patterns.

Authors:  A López-Ferrer; V Curull; C Barranco; M Garrido; J Lloreta; F X Real
Journal:  Am J Respir Cell Mol Biol       Date:  2001-01       Impact factor: 6.914

3.  Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.

Authors:  U Manne; H L Weiss; W E Grizzle
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

4.  Regulation of the intestinal mucin MUC2 gene expression in vivo: evidence for the role of promoter methylation.

Authors:  A Gratchev; A Siedow; C Bumke-Vogt; M Hummel; H D Foss; M L Hanski; U Kobalz; B Mann; H Lammert; U Mansmann; H Stein; E O Riecken; C Hanski
Journal:  Cancer Lett       Date:  2001-07-10       Impact factor: 8.679

5.  Transcriptional activation of the MUC2 gene by p53.

Authors:  Keizou Ookawa; Toshihiro Kudo; Shu Aizawa; Hiroshi Saito; Shigeki Tsuchida
Journal:  J Biol Chem       Date:  2002-10-08       Impact factor: 5.157

Review 6.  Epidemiology and molecular genetics of colorectal cancer.

Authors:  B Fahy; R J Bold
Journal:  Surg Oncol       Date:  1998 Nov-Dec       Impact factor: 3.279

7.  Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis.

Authors:  A E Biemer-Hüttmann; M D Walsh; M A McGuckin; L A Simms; J Young; B A Leggett; J R Jass
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

8.  Differential expression of the chromosome 11 mucin genes in colorectal cancer.

Authors:  P A Sylvester; N Myerscough; B F Warren; I Carlstedt; A P Corfield; P Durdey; M G Thomas
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

9.  Colorectal cancer in mice genetically deficient in the mucin Muc2.

Authors:  Anna Velcich; WanCai Yang; Joerg Heyer; Alessandra Fragale; Courtney Nicholas; Stephanie Viani; Raju Kucherlapati; Martin Lipkin; Kan Yang; Leonard Augenlicht
Journal:  Science       Date:  2002-03-01       Impact factor: 47.728

10.  Expression of MUC5AC in colorectal carcinoma and relationship with prognosis.

Authors:  Belma Kocer; Atilla Soran; Sibel Erdogan; Melih Karabeyoglu; Osman Yildirim; Abdullah Eroglu; Betül Bozkurt; Omer Cengiz
Journal:  Pathol Int       Date:  2002-07       Impact factor: 2.534

View more
  19 in total

1.  An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

2.  Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.

Authors:  Shiv Ram Krishn; Sukhwinder Kaur; Lynette M Smith; Sonny L Johansson; Maneesh Jain; Asish Patel; Shailendra K Gautam; Michael A Hollingsworth; Ulla Mandel; Henrik Clausen; Wing-Cheong Lo; Wai-Tong Louis Fan; Upender Manne; Surinder K Batra
Journal:  Cancer Lett       Date:  2016-02-16       Impact factor: 8.679

3.  Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.

Authors:  Do Trong Khanh; Eiji Mekata; Ken-ichi Mukaisho; Hiroyuki Sugihara; Tomoharu Shimizu; Hisanori Shiomi; Satoshi Murata; Shigeyuki Naka; Hiroshi Yamamoto; Yoshihiro Endo; Tohru Tani
Journal:  Cancer Sci       Date:  2013-05-21       Impact factor: 6.716

4.  MUC5AC/β-catenin expression and KRAS gene alteration in laterally spreading colorectal tumors.

Authors:  Kosaburo Nakae; Hiroyuki Mitomi; Tsuyoshi Saito; Michiko Takahashi; Takashi Morimoto; Yasuhiro Hidaka; Naoto Sakamoto; Takashi Yao; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

5.  An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: III. Expressions of EMA, CEA, CA19-9, CDX-2, p53, Ki-67 antigen, TTF-1, vimentin, and p63 in normal mucosa and in 42 cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

6.  TRPM5-mediated calcium uptake regulates mucin secretion from human colon goblet cells.

Authors:  Sandra Mitrovic; Cristina Nogueira; Gerard Cantero-Recasens; Kerstin Kiefer; José M Fernández-Fernández; Jean-François Popoff; Laetitia Casano; Frederic A Bard; Raul Gomez; Miguel A Valverde; Vivek Malhotra
Journal:  Elife       Date:  2013-05-28       Impact factor: 8.140

7.  Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.

Authors:  Donglin Liu; Chien-Hsing Chang; David V Gold; David M Goldenberg
Journal:  Oncotarget       Date:  2015-02-28

8.  A rare case of nonfamilial polyposis coli with immunohistochemical observations with mucin product genes MUC2 and MUC5AC in adenoma-carcinoma progression.

Authors:  Sanjay D Deshmukh; Siddhi Gaurish Khandeparkar; Bageshri P Gogate; Mrunal Kesari
Journal:  South Asian J Cancer       Date:  2014-10

9.  Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.

Authors:  Xiuying Xiao; Lisha Wang; Ping Wei; Yayun Chi; Dali Li; Qifeng Wang; Shujuan Ni; Cong Tan; Weiqi Sheng; Menghong Sun; Xiaoyan Zhou; Xiang Du
Journal:  J Transl Med       Date:  2013-06-20       Impact factor: 5.531

10.  Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.

Authors:  Khayal Al-Khayal; Maha Abdulla; Omar Al-Obeed; Wael Al Kattan; Ahmad Zubaidi; Mansoor-Ali Vaali-Mohammed; Abdulmalik Alsheikh; Rehan Ahmad
Journal:  Oncol Rep       Date:  2015-12-17       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.